NO20083318L - Farmasoytiske sammensetninger inneholdende protein NMA0939 - Google Patents

Farmasoytiske sammensetninger inneholdende protein NMA0939

Info

Publication number
NO20083318L
NO20083318L NO20083318A NO20083318A NO20083318L NO 20083318 L NO20083318 L NO 20083318L NO 20083318 A NO20083318 A NO 20083318A NO 20083318 A NO20083318 A NO 20083318A NO 20083318 L NO20083318 L NO 20083318L
Authority
NO
Norway
Prior art keywords
nma0939
protein
pharmaceutical compositions
compositions containing
formulations
Prior art date
Application number
NO20083318A
Other languages
English (en)
Inventor
Sonia Gonzalez Blanco
Rolando Pajon Feyt
Gretel Sardinas Garcia
Agustin Lage Castellanos
Daniel Yero Corona
Darien Garcia Diaz
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Publication of NO20083318L publication Critical patent/NO20083318L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Sammendrag Den foreliggende oppfinnelse angår feltet medisin, særlig utvikling av farmasøytiske formuleringer som inneholder NMA0939-protein. Formuleringer beskrevet ifølge foreliggende oppfinnelse er i stand til å gi beskyttelse ovenfor forskjellige sykdommer forårsaket eller ikke forårsaket av patogene midler. NMA0939-protein ble identifisert som en Neisseria meningitidis ytre membran vesikkelkomponent og den ble oppnådd gjennom rekombinant DNA-teknologi hvor dens immunogenisitet og beskyttende aktivitet ble evaluert i dyremodeller. Pga. den høye graden av konservering som det NMA0939kodende genet har vist har farmasøytiske sammensetninger som inneholder dette proteinet verdi som induserere av en kryssreaktiv immunrespons. Formuleringer ifølge oppfinnelsen er anvendelige innenfor feltet humanmedisin.
NO20083318A 2005-12-29 2008-07-28 Farmasoytiske sammensetninger inneholdende protein NMA0939 NO20083318L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20050279A CU23549A1 (es) 2005-12-29 2005-12-29 Composiciones farmacéuticas que contienen la proteína nma0939
PCT/CU2006/000019 WO2007073705A2 (es) 2005-12-29 2006-12-28 Composiciones farmacéuticas que contienen la proteína nma0939

Publications (1)

Publication Number Publication Date
NO20083318L true NO20083318L (no) 2008-09-26

Family

ID=38218331

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083318A NO20083318L (no) 2005-12-29 2008-07-28 Farmasoytiske sammensetninger inneholdende protein NMA0939

Country Status (13)

Country Link
US (1) US20090208521A1 (no)
EP (1) EP1977761A2 (no)
KR (1) KR20080081198A (no)
CN (1) CN101443037A (no)
AR (1) AR058735A1 (no)
AU (1) AU2006331224A1 (no)
BR (1) BRPI0620867A2 (no)
CA (1) CA2633424A1 (no)
CU (1) CU23549A1 (no)
NO (1) NO20083318L (no)
RU (1) RU2008131066A (no)
WO (1) WO2007073705A2 (no)
ZA (1) ZA200805355B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018042015A1 (en) * 2016-09-02 2018-03-08 Glaxosmithkline Biologicals Sa Vaccines for neisseria gonorrhoeae

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2371032A1 (en) * 1999-04-30 2000-11-09 Chiron Corporation Neisseria genomic sequences and methods of their use
GB0103424D0 (en) * 2001-02-12 2001-03-28 Chiron Spa Gonococcus proteins
CA2493124C (en) * 2002-08-02 2014-04-29 Glaxosmithkline Biologicals S.A. Vaccine
CU23236A1 (es) * 2003-12-03 2007-09-26 Ct Ingenieria Genetica Biotech PROTEINA NMB0928 Y SU USO EN FORMULACIONES FARMACéUTICAS P

Also Published As

Publication number Publication date
CA2633424A1 (en) 2007-07-05
RU2008131066A (ru) 2010-02-10
CN101443037A (zh) 2009-05-27
BRPI0620867A2 (pt) 2011-11-29
US20090208521A1 (en) 2009-08-20
EP1977761A2 (en) 2008-10-08
AU2006331224A1 (en) 2007-07-05
ZA200805355B (en) 2009-04-29
CU23549B7 (no) 2010-07-20
WO2007073705A3 (es) 2007-09-13
CU23549A1 (es) 2010-07-20
WO2007073705A2 (es) 2007-07-05
AR058735A1 (es) 2008-02-20
KR20080081198A (ko) 2008-09-08

Similar Documents

Publication Publication Date Title
Gerits et al. New approaches to combat Porphyromonas gingivalis biofilms
Mattos-Graner et al. Lessons learned from clinical studies: roles of mutans streptococci in the pathogenesis of dental caries
PH12021550479A1 (en) Dengue vaccine unit dose and administration thereof
NO20083940L (no) Fremgangsmater for redusering av proteinaggregering
AU2009326524A8 (en) Use of Flt3 ligand for strengthening immune responses in RNA immunization
NO20073868L (no) Levende attenuert rotavirus vaksine for oral administrering
GB201018518D0 (en) Novel endolysin
WO2011110655A3 (en) Immunogenic composition or vaccine against gram - negative bacterial, for example neiserial, infection or disease
MY162324A (en) Immunomodulatory polypeptides derived from il-2 and their use thereof in the therapeutic of cancer and chronic infections
CY1118934T1 (el) Παρασκευη ενεργης ακρως φωσφορυλιωμενης ανθρωπινης ν-ακετυλογαλακτοζαμινης-6-σουλφατασης και χρησεις αυτης
NO20064584L (no) Tetrahydropyridoindolderivater
MX2009004243A (es) Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal.
BRPI0414721A (pt) formulações estabilizadas de fosfatidilserina
NO20083905L (no) Nye pyron-indol derivater og fremgangsmate for deres fremstilling
ATE501644T1 (de) Flüssige formulierungen enthaltend carotinoide
NO20084524L (no) Farmasoytisk sammensetning inneholdende NMB0938-protein
BR112015013625A2 (pt) adjuvante de vacinação, preparação e vacinas contendo o mesmo
NO20084525L (no) Farmasoytiske sammensetninger inneholdende NMB0606-protein
BR112014007491A2 (pt) sequências de aminoácidos para o controle de patógenos
Murakami et al. Impact of type and duration of application of commercially available oral moisturizers on their antifungal effects
NO20063017L (no) Protein NMB0928 og anvendelse derav i farmasoytiske formuleringer
WO2007073705A3 (es) Composiciones farmacéuticas que contienen la proteína nma0939
Retzinger¹ et al. the role of hygiene in allergy
Jeong et al. Different strategies for producing naturally soluble form of common cytokine receptor γ chain
CU23528A1 (es) Composición farmacéutica que comprende la proteína nmb0848

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application